Overview Request Sample Pages Request Customization Download PDF
You are viewing: China Wound Care Market analysis
Part of: Wound Care Market (Global)

The China Wound Care Market was valued at $12893.2 Million in 2025 and projected to reach to $16087.5 Million by 2030, representing a compound annual growth rate of 4.5%. China's wound care market is positioned for steady expansion through 2030, driven by demographic shifts, healthcare system modernization, and increased chronic disease prevalence.

China Wound Care Market Trends and Insights

  • This steady growth reflects China's aging population, rising prevalence of chronic wounds, and increasing healthcare expenditure across urban and rural regions.
  • China's healthcare infrastructure modernization and growing adoption of advanced wound management solutions are driving market expansion during this forecast period. The wound care sector in China is characterized by a mix of traditional and innovative treatment approaches, with China gradually shifting toward advanced dressings and biologics.
  • China's large patient base, combined with government initiatives to improve wound care standards, creates significant opportunities for both domestic and international market players.
  • By 2030, China is expected to maintain its position as a key growth market within the Asia Pacific region, supported by rising awareness and improved access to specialized wound care products..

Key Market Statistics

  • CAGR (2025-2030) 4.5% CAGR
  • Market Size, 2025 ~USD 12893.2 Million
  • Forecast, 2030 ~USD 16087.5 Million
  • Country China

China Wound Care Market Overview

Aging Population Driving Demand :

China's rapidly aging demographic, with over 280 million people aged 60+, is significantly increasing the prevalence of chronic wounds, diabetic ulcers, and pressure injuries, creating sustained demand for advanced wound care solutions.

Healthcare Infrastructure Modernization :

Substantial investments in rural healthcare facilities and urban hospital upgrades across China are expanding access to advanced wound care products, particularly in tier-2 and tier-3 cities where penetration remains underdeveloped.

Rising Chronic Disease Burden :

Diabetes prevalence in China exceeds 11% of the adult population, with approximately 140 million diagnosed cases. This epidemic directly correlates with increased diabetic foot ulcer incidence, driving wound care market expansion.

Government Healthcare Spending Growth :

China's healthcare expenditure is projected to reach 8-9% of GDP by 2030, with government initiatives prioritizing chronic disease management and wound care accessibility in both urban and underserved rural regions.

China Wound Care Market Dynamics

  • The 4.5% CAGR reflects a maturing market with growing adoption of advanced wound care technologies in major urban centers, while significant growth opportunities remain in rural regions with improving healthcare infrastructure. Key growth catalysts include government reimbursement policy reforms, rising patient awareness of advanced wound care benefits, and increasing participation of international manufacturers in the Chinese market.
  • However, price sensitivity and competition from domestic manufacturers may moderate growth rates compared to global markets, requiring localized strategies and value-based pricing approaches..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Stryker Corporation
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • China's wound care market reaches USD 12,893.2M in 2025 and is forecast to grow to USD 16,087.5M by 2030 at a 4.5% CAGR.
    • China's aging demographic and rising chronic disease burden are primary drivers of sustained wound care demand through 2030.
    • China is transitioning from basic wound care to advanced dressings and biologics, reflecting healthcare modernization efforts.
    • Government healthcare reforms and improved rural access are expanding China's addressable wound care market across all regions.

    Wound Care Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment BIOLOGICAL SKIN SUBSTITUTES (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6.5% from 2025 to 2030
    Largest Segment ADVANCED WOUND CARE PRODUCTS (Product)
    Market Size Base Year (Billions) ~USD 22.25 (2025)
    Revenue Forecast (Billions) ~USD 30.48 (2030)
    Segments Covered Product, Type, Property

    China Wound Care Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Advanced Wound Care Products
    • Surgical Wound Care Products
    • Traditional Wound Care Products

    By Type

    • Absorbent Pads
    • Acellular Animal-Derived Products
    • Advanced Wound Dressings
    • Alginate Dressings
    • Bandages
    • Biological Skin Substitutes
    • Biosynthetic Products
    • Collagen Dressings
    • Collagen-Based Sealants
    • Compressions
    • Debridement Devices & Accessories
    • Devices & Accessories
    • Fibrin-Based Sealants
    • Film Dressings
    • First Aid Plasters
    • Fixations
    • Foam Dressings
    • Gauzes
    • Human Donor Tissue-Derived Products
    • Hydrocolloid Dressings
    • Hydrofiber Dressings
    • Hydrogel Dressings
    • Island Dressings
    • Non-Silicone Dressings
    • Npwt Devices & Accessories
    • Other Advanced Wound Care Dressings
    • Other Devices & Accessories
    • Other Traditional Wound Care Products
    • Silicone Dressings
    • Staplers
    • Superabsorbent Dressings
    • Sutures
    • Synthetic Adhesives
    • Tissue Adhesives, Sealants, And Glues
    • Topical Agents
    • Wound Assessment & Monitoring Devices
    • Wound Contact Layers

    By Property

    • Antimicrobial Dressings
    • Non-Antimicrobial Dressings

    Target Audience

    • Medical Device Manufacturers : Companies seeking to enter or expand in China's wound care market need localized insights on regulatory requirements, competitive positioning, distribution channels, and pricing strategies to successfully commercialize products.
    • Healthcare Investors & PE Firms : Investment professionals evaluating opportunities in China's healthcare sector require detailed market sizing, growth projections, competitive dynamics, and risk assessments to make informed capital allocation decisions.
    • Hospital & Healthcare Providers : Chinese hospital networks and healthcare systems need market intelligence on product innovations, supplier options, procurement trends, and cost-effectiveness data to optimize wound care service delivery and procurement strategies.
    • Pharmaceutical & Biotech Companies : Organizations developing wound care therapeutics and advanced treatments require China-specific market data, clinical adoption patterns, and reimbursement landscapes to guide R&D investments and commercialization planning.
    • Market Research & Consulting Firms : Research organizations and consultants serving healthcare clients need comprehensive China wound care market data to support client advisory work, competitive analysis, and strategic recommendations.

    Key Companies in the China Wound Care Market

    CompanyHQOwnershipStrongest segments
    KINDRED HEALTHCARE INC.United StatesPrivate CompanyInjectable drug delivery utilization (IV, subcutaneous, infusions),Oral drug delivery utilization (solid and liquid forms),Topical, transdermal, and other routes,
    BEIERSDORF AGGermanyPublic CompanyMass skin and body care (NIVEA, Labello, ATRIX, 8x4, HIDROFUGAL, regional brands),Dermocosmetics and therapeutic care (Eucerin, Aquaphor, SKIN STORIES),Premium and luxury skincare (La Prairie, Chantecaille),
    ADVANCED MEDICAL SOLUTIONSUnited KingdomPublic CompanyTissue adhesives (LiquiBand family),Advanced woundcare dressings (ActivHeal and white label),Haemostats and biosurgical products (RESORBA, Seal-G, Vitalitec),
    ALLIQUA BIOMEDICALUnited StatesPublic CompanyWound care hydrogels,Medical diagnostics hydrogels,Transdermal drug delivery hydrogels,
    ANSELL LIMITEDAustraliaPublic CompanyHealthcare examination and single-use gloves,Surgical and specialty healthcare gloves,Cleanroom and sterile garments/consumables,
    COVIDIEN LTD.IrelandPrivate CompanyAdvanced Surgical Solutions (stapling, vessel sealing, fixation, ablation, interventional lung and GI),General Surgical Solutions (instruments, sutures, electrosurgery),Peripheral and Neurovascular Therapies,
    HENRY SCHEINUnited StatesPublic CompanyGlobal Distribution and Value-Added Services,Global Specialty Products,Global Technology,
    HILL-ROM HOLDINGS, INC.United StatesPrivate CompanyPatient Support Systems (beds, surfaces, mobility, IT, services),Front Line Care (monitoring, diagnostics, respiratory health),Surgical Solutions (tables, lights, pendants, positioning),
    SOLVENTUMUnited StatesPublic CompanyMedsurg,Dental Solutions,Health Information Systems,
    SMITH+NEPHEWUnited KingdomPublic CompanyOrthopaedics (Knee, Hip, Trauma & Extremities, Other Reconstruction),Sports Medicine & ENT,Advanced Wound Care,
    CARDINAL HEALTHUnited StatesPublic CompanyBranded and Generic Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,Medical, Surgical, and Laboratory Products (Branded and National Brand),
    MöLNLYCKE ABSwedenPrivate CompanyWound Care (acute and chronic),Operating Room Solutions (drapes, gowns, trays, instruments),Gloves,
    CONVATEC GROUP PLCUnited KingdomPublic CompanyAdvanced Wound Care,Ostomy Care,Continence Care,
    ORGANOGENESIS INC.United StatesPublic CompanyBioengineered skin substitutes (Apligraf, Dermagraft, TransCyte),Placental allografts (Affinity, Novachor, NuShield, CYGNUS Dual, VIA Matrix, SimpliMax),Collagen and biosynthetic matrices (PuraPly AM/SX/MZ, PuraForce, FortiShield),
    PAUL HARTMANN AGGermanyPublic CompanyWound Care,Incontinence Management,Infection Management,
    MIMEDX GROUP, INC.United StatesPublic CompanyWound care allografts (EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, EPIEFFECT),Surgical and burn allografts (AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, AMNIOEFFECT),Other / alliances and adjunct solutions (e.g., Vaporox-linked offerings),
    OWENS & MINORUnited StatesPublic CompanyIn-home diabetes care and delivery,Home respiratory therapy (oxygen and non-invasive ventilation),Obstructive sleep apnea (CPAP/BiPAP and support),
    ESSITY AKTIEBOLAGSwedenPublic CompanyHealth & Medical (incontinence, wound care, compression, orthopedics, digital solutions),Consumer Goods (baby, femcare, leakproof apparel, consumer tissue, personal care),Professional Hygiene (away-from-home tissue, soaps, sanitizers, dispensers, data-driven cleaning),
    INTEGRA LIFESCIENCES CORPORATIONUnited StatesPublic CompanyCodman Specialty Surgical (neurosurgery & neurocritical care),Tissue Technologies – acute & chronic wound care,Tissue Technologies – surgical reconstruction & nerve/tendon repair,
    AVERY DENNISON CORPORATIONUnited StatesPublic CompanyPressure-sensitive label materials,Graphics and reflective products,Branding solutions (tickets, tags, embellishments, sustainable packaging),

    KINDRED HEALTHCARE INC.

    Kindred Healthcare Inc. is a private healthcare company founded in 1985 and headquartered in the United States. With 64,200 employees, it operates as a major provider of healthcare services across the country.

    BEIERSDORF AG

    Beiersdorf AG is a German public company founded in 1882 that operates in the healthcare and consumer goods sectors. The company employs 21,589 people and maintains a significant international presence.

    ADVANCED MEDICAL SOLUTIONS

    Advanced Medical Solutions is a United Kingdom-based public company founded in 1991 with 1,800 employees. The company develops and manufactures advanced medical products and wound care solutions.

    ALLIQUA BIOMEDICAL

    Alliqua Biomedical is a United States-based public company founded in 1997 with a small team of 6 employees. The company focuses on biomedical innovations and specialized healthcare solutions.

    ANSELL LIMITED

    Ansell Limited is an Australian public company founded in 1893 with 15,000 employees. It is a global leader in protective solutions and healthcare products across multiple industries.

    COVIDIEN LTD.

    Covidien Ltd. is a private medical device and healthcare company incorporated in Ireland in 2007 with 39,500 employees. It operates globally in the medical technology sector.

    HENRY SCHEIN

    Henry Schein is a United States-based public company founded in 1932 with 25,000 employees. It is a leading distributor of healthcare products and services to medical, dental, and veterinary professionals.

    HILL-ROM HOLDINGS, INC.

    Hill-Rom Holdings, Inc. is a United States-based private company founded in 1915 with 10,000 employees. The company manufactures and distributes medical devices and healthcare equipment.

    SOLVENTUM

    Solventum is a United States-based public company established in 2023 with 20,584 employees. The company operates in the healthcare and technology sectors with a global presence.

    SMITH+NEPHEW

    Smith+Nephew is a United Kingdom-based public company founded in 1856 with 16,988 employees. It is a global medical technology company specializing in orthopedics, wound care, and sports medicine.

    CARDINAL HEALTH

    Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees. It is a major healthcare services and products distributor serving hospitals, pharmacies, and medical facilities.

    MöLNLYCKE AB

    Mölnlycke AB is a Swedish private company founded in 1849 with 8,463 employees. The company specializes in medical devices and healthcare solutions with a global reach.

    CONVATEC GROUP PLC

    ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees. It develops and manufactures medical devices and products for ostomy, continence, and wound care.

    ORGANOGENESIS INC.

    Organogenesis Inc. is a United States-based public company with 854 employees specializing in regenerative medicine and advanced wound care solutions. The company develops innovative biological products for healthcare applications.

    PAUL HARTMANN AG

    Paul Hartmann AG is a German public company founded in 1818 with 10,066 employees. It is a leading manufacturer of medical and healthcare products including wound care and hygiene solutions.

    MIMEDX GROUP, INC.

    MiMedx Group, Inc. is a United States-based public company founded in 2006 with 808 employees. The company develops and distributes regenerative medicine products for wound care and surgical applications.

    OWENS & MINOR

    Owens & Minor is a United States-based public company founded in 1882 with 6,500 employees. It is a healthcare services company specializing in medical device and pharmaceutical distribution.

    ESSITY AKTIEBOLAG

    Essity Aktiebolag is a Swedish public company founded in 1849 with 36,000 employees. It is a leading hygiene and health company producing personal care and professional hygiene products.

    INTEGRA LIFESCIENCES CORPORATION

    Integra LifeSciences Corporation is a United States-based public company founded in 1989 with 4,427 employees. It develops and manufactures medical devices and regenerative medicine products for surgical and orthopedic applications.

    AVERY DENNISON CORPORATION

    Avery Dennison Corporation is a United States-based public company founded in 1935 with 35,000 employees. It manufactures and distributes pressure-sensitive materials, labels, and packaging solutions globally.

    Reasons to Buy this Report

    • Localized Market Insights : Gain deep understanding of China-specific dynamics including regional variations, urban-rural disparities, and tier-city market segmentation essential for targeted market entry and expansion strategies.
    • Competitive Landscape Analysis : Identify key domestic and international competitors operating in China, their market positioning, pricing strategies, and distribution channels to inform competitive differentiation and partnership opportunities.
    • Regulatory & Reimbursement Framework : Understand China's evolving healthcare policies, medical device regulations, insurance coverage mechanisms, and government procurement processes critical for product commercialization and market access.
    • Growth Opportunity Mapping : Pinpoint high-potential segments, underserved regions, and emerging customer needs within China's wound care market to prioritize investment and resource allocation for maximum ROI.
    • Strategic Decision Support : Leverage comprehensive market data and forecasts to support investment decisions, partnership evaluations, product development priorities, and go-to-market strategies specific to the Chinese market.

    Frequently asked questions

    What is the current size of China's wound care market in 2025?

    China's wound care market is valued at USD 12,893.2 million in 2025, representing a significant segment within the Asia Pacific region.

    What is the projected market size for China's wound care sector by 2030?

    China's wound care market is projected to reach USD 16,087.5 million by 2030, growing at a 4.5% compound annual growth rate.

    What factors are driving growth in China's wound care market?

    Key growth drivers in China include an aging population, rising prevalence of chronic wounds, increased healthcare spending, and government initiatives to modernize wound care infrastructure.

    How is China's wound care market evolving in terms of product types?

    China is transitioning from traditional wound care products toward advanced dressings, biologics, and innovative wound management solutions as healthcare standards improve.

    What is the CAGR for China's wound care market between 2025 and 2030?

    China's wound care market is expected to grow at a compound annual growth rate of 4.5% from 2025 to 2030.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the global Wound Care market. Exhaustive secondary research was done to collect information on the wound care industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the wound care market.

    The four steps involved in estimating the market size are:

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global wound care market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the wound care market. The primary sources from the demand side include pharmaceutical companies, biotechnology companies, CROs, pharmacies, medical device companies, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

    The following is a breakdown of the primary respondents:

    Wound Care Market

    Note 1: Other designations include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global wound care market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. The global wound care market was split into various segments and sub-segments based on:

    • List of major players operating in the product market at the regional and/or country level
    • Product mapping of wound care providers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from wound care (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global wound care market

    The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    The research methodology used to estimate the market size includes the following:

    Wound Care Market

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Wound care involves using various products, such as dressings, devices, and biologics, to facilitate the rapid healing and management of wounds. Wound care enables an individual’s injuries to transition into smoother, cost-effective, and treatment-efficient healing.

    Stakeholders

    • Wound Care Product Manufacturers
    • Wound Care Associates
    • Research and Consulting Firms
    • Distributors of Wound Care Devices
    • Contract Manufacturers of Wound Care Products
    • Healthcare Institutes (Hospitals, Medical Schools, Diagnostic Centers, and Outpatient Clinics)
    • Research Institutes
    • Venture Capitalists

    Report Objectives

    • To define, describe, segment, and forecast the global wound care market by product, wound type, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall wound care market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
    • To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region

     

    Get the Full Wound Care Market Report

    Full forecast, segment splits, and company analysis for all Wound Care Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status